SCHEMBL16502145

SCHEMBL16502145

Cc1ccc(N2c3ccc(-c4ccc5ccccc5c4)cc3Cc3cc(-c4cccc5ccccc45)ccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 1/20 0.40
▸ MEN1 O00255 1/20 0.36
▸ GAA P10253 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ TLR9 Q9NR96 1/20 0.36
▸ FLT3 P36888 1/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ HSD17B10 Q99714 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ CYP11B1 P15538 3/20 0.35
▸ CYP11B2 P19099 3/20 0.35
▸ ALK Q9UM73 1/20 0.35
▸ PIM1 P11309 1/20 0.34
▸ EGFR P00533 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16502170 0.94 MEN1 (0.40) METMEN1GAAKMT2ATLR9
SCHEMBL16502153 0.89 ALDH1A1 (0.42) MEN1GAAKMT2ATLR9ALDH1A1
SCHEMBL16502158 0.86 MEN1 (0.43) MEN1GAAKMT2ATLR9ALDH1A1
SCHEMBL16502171 0.86 ALDH1A1 (0.40) MEN1GAAKMT2ATLR9ALDH1A1
SCHEMBL16502126 0.84 ALDH1A1 (0.38) METFLT3ALDH1A1CYP1A2CYP3A4
SCHEMBL10306011 0.81 MET (0.34) METALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL10305984 0.81 PDE6D (0.34) METALDH1A1ALKMCL1ACMSD
SCHEMBL10305934 0.81 CA12 (0.35) METALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL10305952 0.81 MET (0.34) METALDH1A1CYP1A2CYP2C9HPGD
SCHEMBL10305996 0.80 CA12 (0.34) METALDH1A1CYP1A2CYP2C9HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110309341-A1 AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME SUMATION CO., LTD. (JP) 2011-12-22 — — US disclosed
US-20110309341-A1 AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME SUMATION CO., LTD. (JP) 2011-12-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110309341-A1 AMINE POLYMER COMPOUND AND LIGHT EMITTING DEVICE USING THE SAME AHR, HRH3, HRH4 MET 3140/4885MEN1 942/4885GAA 3715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback